Topics
AMD
Clinical Trial Closeup
Coding & Medicare
DME
Editor's Page
Genetics
Imaging & Diagnostics
News
RVO
Stem Cells
Surgical Pearl Video
Surgical Techniques & Tools
Uveitis
Vitrectomy
Current Issue
Archive
CME
News
Risks Associated with Onset of Diabetic Disease
Study: Predicting AMD Progression Remains Complex
Retina Update: Study Analyzes DME Patients' Response to Therapy
Retina Update: Potential Biomarker for DME Proposed
Combined Treatment for PDR: Sequence Matters
Susvimo Implant to Return to the Market
Risk of PDR and DME with Popular Weight-loss Drugs
Study Analyzes Spending on Anti-VEGF Injections
Popular Alzheimer's Drug May Help Prevent AMD
Calling out retina’s ‘head-in-the-sand’ approach to mental health and neovascular AMD
Five events make for a busy summer in retina
In the Lucentis biosimilars wars, there are no winners so far
Study reports potential of OCT to identify vascular damage in severe COVID-19
With FDA approval, pegcetacoplan launches with high awareness—and a few questions
Why are ophthalmologists a definite maybe about biosimilars? Survey provides answers
A deeper dive into anti-VEGF loss to follow-up: Study identifies risk factors
Where are the women in retina? Not at the podium, study reports
Bevacizumab first, aflibercept second cost-effective for DME, Protocol AC finds
With Byooviz, Biogen takes a leap on pricing first U.S. retina biosimilar
New DME treatment trial targets underrepresented populations
A deeper dive into why DAZZLE results of KSI-301 in nAMD ‘disappointed’
Retina Update: Is Vabysmo the next $1 billion anti-VEGF?
Retina Update: Market forces may be gathering to exert price pressures on anti-VEGF drugs
Retina Update: New research challenges previous findings on genetic risk factor for AMD
Retina Update: Finnish researchers add voice to cataract surgery in AMD debate
Retina Update: NEI-supported group is tackling ophthalmology’s diversity problem
Retina Update: COVID-19 dealt retina surgical procedures a big blow; effects may linger for a while
Retina Update: Now director of National Eye Institute, Dr. Michael Chiang comes full circle
Retina Update: A rocky year after approval, brolucizumab finds its niche
Retina Update: Why we need more precise terminology for race, ethnicity
Load More
Current Issue
Table of Contents
Digital Edition
PDF Edition
Archives
Subscription
Connect With Us
Additional Publications
Webinar: Learn More about Stargardt Disease
Watch the Webinar
Learn More about Stargardt Disease
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
View More Publications
Review Of Ophthalmology
Table of Contents
Digital Edition
PDF Edition
Archives
Subscription
A Guide to the Newest Premium IOLs
’Tis The Season for VKC
ARVO Annual Meeting Report
Video Vault
Intraocular Cysticercosis
×
Full Image